Current Progress in Therapeutic Gene Editing for Monogenic Diseases
Year: 2016
Type: review
Abstract: Programmable nucleases allow defined alterations in the genome with ease-of-use, efficiency, and specificity. Their availability has led to accurate and widespread genome engineering, with multiple applications in basic research, biotechnology, and therapy. With regard to human gene therapy, nuclease-based gene editing has facilitated development of a broad range of therapeutic strategies based on both nonhomologous end joining and homology-dependent repair. This review discusses current progress in nuclease-based therapeutic applications for a subset of inherited monogenic diseases including cystic fibrosis, Duchenne muscular dystrophy, diseases of the bone marrow, and hemophilia and highlights associated challenges and future prospects.
Source: Molecular Therapy
DOI: 10.1038/mt.2016.5
Authors: Versha Prakash, Marc Moore, Rafael J Yáñez-Muñoz
Institutions: University of London, Royal Holloway University of London
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W2325985500
